publication date: Sep. 25, 2020

In Brief

$111 million NIH grant awarded to prevent and treat HIV-associated cancers

The Montefiore Health System and Albert Einstein College of Medicine have received a five-year, $111 million grant from NCI to lead the AIDS Malignancy Consortium.

AMC is the only organization worldwide solely dedicated to the study, treatment, and prevention of cancer in this group of people. Joseph Sparano, associate chair for clinical research in the department of oncology at Montefiore, associate director for clinical research at the NCI-designated Albert Einstein Cancer Center, is principal investigator on the grant.

People living with HIV have an increased risk of developing cancer compared with the general population and are more likely to die of cancer. Also, HIV infections are concentrated in marginalized communities in the U.S., primarily among people of color, who make up approximately 70% of new infections.

To address this need, Montefiore developed an HIV Oncology Service, directed by Luca Paoluzzi, a medical oncologist at Montefiore, assistant professor of medicine at Einstein, and the AMC PI at Montefiore and Einstein.

Collaborating with Harris Goldstein, associate dean for scientific resources, director of the NIH-funded Einstein-Rockefeller-CUNY Center for AIDS Research and professor of pediatrics and of microbiology & immunology at Einstein, Sparano has established a scientific working group focused on cancer and HIV that will guide the direction of future collaborative research at the CFAR and AMC.

The group will be co-chaired by Sparano and Howard Strickler, professor and chief of epidemiology in the department of epidemiology & population health at Einstein and Montefiore. It will identify areas of need, evaluate emerging research, and design new clinical trials that will be rolled out at dozens of locations at … Continue reading $111 million NIH grant awarded to prevent and treat HIV-associated cancers

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.